维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Taylor PT"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Tregs and transplantation tolerance 显示文摘	Walsh PT Taylor DK Turk LA	2004	J Clin Invest2004，114，10：	1
2	Treg and transplantation tolerance显示文摘	Walsh PT Taylor DK Turka LA	2004	J Clin Invest2004，114，10：	1
3	Tregs and transplantation tolerance显示文摘	Walsh PT Taylor DK Turks LA	2004	J Clin Invest2004，114，10：	1
4	New guidelines to evaluate the response to treatment in solid tumors= ovarian cancer显示文摘	Taylor PT Haverstiek D	2005	J NatlCancer Inst2005，97，2：	1
5	Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer显示文摘	Berek JS Taylor PT Gordon A	2004	J Clin Oncol2004，22，17：	1
6	Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing pla- tinum concentrations in the kidney显示文摘	Hanigan MH Gallagher BC Taylor PT Jr	1996	Am J Obstet Gynecol1996，175，2：	1
7	Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity显示文摘	Hanigan MH Gallagher BC Taylor PT Jr Large MK	1994	Cancer Res1994，54，22：	1
8	Tregs and transplantation tolerance 显示文摘	Walsh PT Taylor DK Turka LA	2004	J Clin Invest2004，114，：	1
9	Effects of cong-term visual display terminal usage on visual functions 显示文摘	Yeow PT Taylor SP	1991	Optom Ws Sci1991，68，12：	1
10	Effects of short-term VDT usage on visual functions显示文摘	Yeow PT Taylor SP	1989	Optom Vis Sei1989，66，7：	1
11	CA125velocity at relapse is a highly significant predictor of survival post relapse:results of a5-year follow-up survey to a randomized placebo-controlled study of mainte-nance oregovomab immunotherapy in advanced ovarian cancer显示文摘	Berek JS Taylor PT Nicodemus CF	2008	Journal of Immunotherapy2008，31，2：	1
12	Interpretation of pulsatility index in feeder arteries to low-impedance vascular beds显示文摘	Gosling RG Lo PT Taylor MG	1991	Ultrasound Obstet Gynecol1991，1，3：	1
13	New guidelines to evaluate the response to treatment in solid tumors(ovarian cancer)显示文摘	Taylor PT Haverstick D	2005	J Natl Cancer Inst2005，97，2：	1
14	Evolution of late potential ac- tivity in the first six weeks after acute myocardial infarction 显示文摘	Lewis S J Lander PT Taylor PA	1989	Am J Cardiol1989，63，11：	1
15	Microscale high- performance liquid chromatography electrospray tan- dem mass spectrometry assay for cyclosporin A in blood显示文摘	Taylor PJ Jones CE Martin PT	1998	J Chromatogr B1998，705，2：	1
16	Randomized,placebocontrolled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer显示文摘	Berek JS Taylor PT Gordon A	2004	J Clin Oncol2004，22，：	1
17	CA125 velocity at relapseis a highly significant predictor of survival post relapse:results ofa 5-year follow-up survey to a randomized placebo-controlledstudy of maintenance oregovomab immunotherapy in advanced o-varian cancer显示文摘	Berek JS Taylor PT Nicodemus CF	2008	J Immunother2008，31，2：	1
18	New guidelines to evaluate the response to treatment in solid tumors 显示文摘	Taylor PT Haverstick D	2005	J Natl Cancer Inst2005，97，2：	1
19	Selective neck dissection for the treatment of neck metastasis from squamous Cell carcinoma of the head and neck显示文摘	Chepeha DB Hoff PT Taylor R J	2002	Laryngoseope2002，112，3：	1
20	The relationship of blood andurine boron to boron exposure in boraxworkers and the usefulness ofurine -boron as an exposure marker 显示文摘	CulverBD Shen PT Taylor TH	1994	Enviro Health Perspec1994，102，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示